Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia
Study sponsor: AEON Biopharma, Inc. · AEON
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-07-24Actual
Enrollment · participants51Actual
Source updated2024-08-22Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.